CoChat

How to Evaluate a Diagnostic Marker Test: Lessons From the Rise and Fall of Dexamethasone Suppression Test

Nierenberg, Andrew A. · 1988 · JAMA

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

To understand why the dexamethasone suppression test (DST) for the diagnosis of depression became widely accepted and later rejected, we reviewed the sequence of publications in the DST literature. To evaluate the events, we developed and applied concepts of a five-phase process that can be used to assess the clinical utility of diagnostic marker tests. The review showed that when the DST was introduced into the clinical arena, the initial and final two phases of testing (I, IV, and V) had not been adequately conducted. When these phases of testing were suitably checked many years later, the Phase I studies (exploring basic mechanics of test procedures) showed that dexamethasone had variable bioavailability and that the cortisol assay procedure was unreliable. The Phase IV and V studies (examining test results in groups with suitably broad spectrums of cases and controls) showed that the test did not differentiate depression from most pertinent comorbid conditions. Beyond application to the specific problems of the DST, the proposed five phases of development and evaluation for diagnostic marker tests can be used to plan suitable research and avoid similar problems in the future. (JAMA1988;259:1699-1702)

Overview

Integrity signals

Registry

Crossref · 10.1001/jama.1988.03720110061036

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

The publisher hasn’t deposited this paper’s reference list.

Cited by

See all 130

Metadata

Authors
Nierenberg, A. A.
Corresponding author
Nierenberg, Andrew A.
Venue
JAMA
Published
1988-03-18
Volume
259
Issue
11
Pages
1699
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W7214187784
Cited by
6
References
0
Citations by year
2012: 1
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Locations
JAMA (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
dexamethasone suppression test, depression diagnosis, cortisol assay, test evaluation, clinical utility, research design, comorbidities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How to Evaluate a Diagnostic Marker Test: Lessons From the Rise and Fall of Dexamethasone Suppression Test. https://app.cochat.ai/papers/10.1001/jama.1988.03720110061036
The paper
Nierenberg, A. A. (1988). How to Evaluate a Diagnostic Marker Test: Lessons From the Rise and Fall of Dexamethasone Suppression Test. JAMA. https://doi.org/10.1001/jama.1988.03720110061036

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.